ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
FDA Panel Backs Fibanserin, the First Female Libido Drug
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 19363" data-attributes="member: 3"><p>On Thursday June 4, 2015, the panel of advisers to the U.S. Food and Drug Administration voted 18 to 6 to recommend that the agency approve flibanserin— nicknamed ‘women’s Viagra’ — as the first prescription treatment to boost libido in women. The contingency? That the drug’s manufacturer, Sprout Pharmaceutical, develops measures to limit safety risks. Flibanserin’s risks include low blood pressure and fainting.</p><p></p><p>“I have serious, serious, serious safety concerns,” said Dr. Walid Gellad of the University of Pittsburgh, a panel member who still voted to recommend approval, reports NBC News. “The benefits are modest, maybe less than modest. But I think that puts it in good company with other approved drugs.”</p><p></p><p>Flibanserin, a pink pill that would be taken daily at bedtime, would be approved to treat hypoactive sexual desire disorder.</p><p></p><p>The positive recommendation is a major victory for a drug that’s been twice rejected by the FDA since 2010 due to its minimal benefits and safety concerns. </p><p></p><p><a href="http://www.dddmag.com/news/2015/06/fda-panel-backs-female-libido-drug?et_cid=4608750&et_rid=449166332&location=top" target="_blank">http://www.dddmag.com/news/2015/06/fda-panel-backs-female-libido-drug?et_cid=4608750&et_rid=449166332&location=top</a></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 19363, member: 3"] On Thursday June 4, 2015, the panel of advisers to the U.S. Food and Drug Administration voted 18 to 6 to recommend that the agency approve flibanserin— nicknamed ‘women’s Viagra’ — as the first prescription treatment to boost libido in women. The contingency? That the drug’s manufacturer, Sprout Pharmaceutical, develops measures to limit safety risks. Flibanserin’s risks include low blood pressure and fainting. “I have serious, serious, serious safety concerns,” said Dr. Walid Gellad of the University of Pittsburgh, a panel member who still voted to recommend approval, reports NBC News. “The benefits are modest, maybe less than modest. But I think that puts it in good company with other approved drugs.” Flibanserin, a pink pill that would be taken daily at bedtime, would be approved to treat hypoactive sexual desire disorder. The positive recommendation is a major victory for a drug that’s been twice rejected by the FDA since 2010 due to its minimal benefits and safety concerns. [url]http://www.dddmag.com/news/2015/06/fda-panel-backs-female-libido-drug?et_cid=4608750&et_rid=449166332&location=top[/url] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
FDA Panel Backs Fibanserin, the First Female Libido Drug
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top